NovaBay Pharmaceuticals, Inc. 4
4 · NovaBay Pharmaceuticals, Inc. · Filed Jul 7, 2017
Insider Transaction Report
Form 4
Li Xinzhou
10% OwnerOther
Transactions
- Award
stock option (right to buy)
2017-07-03+5,248→ 5,248 totalExercise: $3.75From: 2017-08-01Exp: 2027-07-03→ common stock (5,248 underlying)
Footnotes (2)
- [F1]option vests in equal installments over the next six months so that they are fully vested by Dec 31, 2017
- [F2]Granted as compensation as a director for Q3 and Q4 2017, pursuant to the 2017 Non-Employee Director Plan